India’s COVID-19 case tally crosses 17K mark on Wednesday

India’s COVID-19 case tally crosses 17K mark on Wednesday

India reported a spike of 17,425 new COVID-19 cases on Wednesday. The new incidences pushed the national case tally to 11,156,748. The active cases now stand at 1,70,443 after recording 14,071 new discharges and 87 deaths in the past 24 hours. The total recoveries have surged to 10,824,233, and the death toll reached 1,57,471.

Maharashtra reported the highest single-day spike of 9,855 COVID-19 cases on Wednesday. The state’s active case tally breached the 80,000 mark to reach 82,343. Pune, Nagpur and Amravati districts, along with Mumbai city, contributed to around 40% of the new cases in the state. As many as 6,559 patients were discharged in the past 24 hours. 42 recent fatalities pushed the death toll to 52,280. The total confirmed case tally has reached 2,179,185, while the cumulative recoveries stand at 2,043,349.

“Of a total of 16,509,506 laboratory samples tested thus far, 2,179,185 have returned positive, with over 88,000 samples being tested in the last 24 hours,” said State Surveillance Officer Dr Pradeep Awate, adding that the state’s case-fatality rate had dipped to 2.40%.

Kerala reported 2,765 new cases, 4,031 discharges and 15 deaths on Wednesday. The total case tally of the state has risen to 10,67,045. The active cases stand at 45,992, as the total recoveries reach 1,016,515 and the death toll adds up to 4,242.

A total of 1.66 crore beneficiaries have been vaccinated for COVID-19 in India so far, according to the union health ministry’s provisional report. On March 3, over 9.94 lakh beneficiaries were vaccinated. Of these, 8.31 lakh beneficiaries were given the first shot of the two-dose regime. About 1.62 lakh healthcare and frontline workers received the second dose, the ministry added.

The second dose of COVID-19 vaccination started for beneficiaries who have completed 28 days since receiving the first shot. The emergency use approval granted by the Drugs Controller General of India (DCGI) accords a window of four to six weeks for the second dose to be administered.